Update on outcome measure development for large vessel vasculitis: Report from OMERACT 12

Journal of Rheumatology

Volumn 42, Issue 12, 2015, Pages 2465-2469

  Aydin, Sibel Zehra ^a   Direskeneli, Haner ^b   Sreih, Antoine ^c   Alibaz Oner, Fatma ^b   Gul, Ahmet ^d   Kamali, Sevil ^b   Hatemi, Gulen ^e   Kermani, Tanaz ^f   Mackie, Sarah L ^g   Mahr, Alfred ^h   Meara, Alexa ⁱ   Milman, Nataliya ^j   Nugent, Heidi ^k   Robson, Joanna ^l   Tomasson, Gunnar ^m   Merkel, Peter A ^c  

^a KOÇ UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j UNIVERSITY OF OTTAWA   (Canada)

^k Bucks   (United Kingdom)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

Giant cell arteritis; Large vessel; Outcomes; Takayasu arteritis; Vasculitis

Indexed keywords

ANCA ASSOCIATED VASCULITIS; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL (TOPIC); DELPHI STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXTENT INDEX-TAKAYASU; GIANT CELL ARTERITIS; HUMAN; INDIAN TAKAYASU ARTERITIS ACTIVITY SCORE 2010; INTERVIEW; LARGE VESSEL VASCULITIS; MEDICAL EXPERT; MEDICAL OUTCOMES STUDY SHORT FORM-36 QUESTIONNAIRE; MEDICAL RESEARCH; MULTIDIMENSIONAL ASSESSMENT OF FATIGUE SCORE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SCORING SYSTEM; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; CONSENSUS DEVELOPMENT; DIAGNOSTIC IMAGING; FEMALE; INFORMATION PROCESSING; MALE; PRACTICE GUIDELINE; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DELPHI TECHNIQUE; FEMALE; FOCUS GROUPS; GIANT CELL ARTERITIS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITATIVE RESEARCH; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS; VASCULITIS;

EID: 84948799013     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141144     Document Type: Article

References (24)

1. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
2. Terao C, Yoshifuji H, Mimori T. Recent advances in Takayasu arteritis. Int J Rheum Dis 2014;17:238-47.
3. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine 2009;88:221-6.
4. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 2012;71:1329-34.
5. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2010;69:780-1.
6. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
7. Direskeneli H, Aydin SZ, Kermani TA, Matteson EL, Boers M, Herlyn K, et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011;38:1471-9.
8. Alibaz-Oner F, Aydin SZ, Direskeneli H. Recent advances in Takayasu's arteritis. Eur J Rheumatol 2014;1:24-30.
9. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
10. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
11. Henes JC, Mueller M, Pfannenberg C, Kanz L, Koetter I. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol 2011;29:S43-8.
12. Direskeneli H, Aydin SZ, Merkel PA. Disease assessment in Takayasu's arteritis. Rheumatology 2013;52:1735-6.
13. Sivakumar MR, Misra RN, Bacon PA, for the IRAVAS group. The Indian perspective of Takayasu arteritis and development of a disease extent index (Dei.Tak) to assess Takayasu arteritis. Rheumatology 2005;44 Suppl 3:iii6-7.
14. Aydin SZ, Yilmaz N, Akar S, Aksu K, Kamali S, Yucel E, et al. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu. Rheumatology 2010;49:1889-93.
15. Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 2013;52:1795-801.
16. Tomasson G, Boers M, Walsh M, La Valley M, Cuthbertson D, Carette S, et al. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 2012;64:273-9.
17. Herlyn K, Hellmich B, Seo P, Merkel PA. Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res 2010;62:1639-45.
18. Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O, et al. Impaired quality of life, disability and mental health in Takayasu's arteritis. Rheumatology 2013;52:1898-904.
19. Akar S, Can G, Binicier O, Aksu K, Akinci B, Solmaz D, et al. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 2008;27:859-65.
20. Abularrage CJ, Slidell MB, Sidawy AN, Kreishman P, Amdur RL, Arora S. Quality of life of patients with Takayasu's arteritis. J Vasc Surg 2008;47:131-6; discussion 6-7.
21. Kupersmith MJ, Speira R, Langer R, Richmond M, Peterson M, Speira H, et al. Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthalmol 2001; 21:266-73.
22. Hellmann DB, Uhlfelder ML, Stone JH, Jenckes MW, Cid MC, Guillevin L, et al. Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum 2003;49:819-25.
23. Grayson PC, Amudala NA, McAlear CA, Leduc RL, Shereff D, Richesson R, et al. Illness perceptions and fatigue in systemic vasculitis. Arthritis Care Res 2013;65:1835-43.
24. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT Filter 2.0. J Clin Epidemiol 2014;67:745-53.